{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:46:18Z","timestamp":1790837178233,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00705-017-3653-1","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T09:15:53Z","timestamp":1511169353000},"page":"609-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients"],"prefix":"10.1007","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-0760","authenticated-orcid":false,"given":"Halef Okan","family":"Do\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyit Ali","family":"B\u00fcy\u00fcktuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Kapancik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Bakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"3653_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.antiviral.2016.06.011","volume":"132","author":"E Akinci","year":"2016","unstructured":"Akinci E, Bodur H, Sunbul M, Leblebicioglu H (2016) Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever. Antivir Res 132:233\u2013243. \n                        https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.011","journal-title":"Antivir Res"},{"key":"3653_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijid.2007.09.010","volume":"12","author":"MA \u00c7evik","year":"2008","unstructured":"\u00c7evik MA, Erbay A, Bodur H et al (2008) Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 12:374\u2013379. \n                        https:\/\/doi.org\/10.1016\/j.ijid.2007.09.010","journal-title":"Int J Infect Dis"},{"key":"3653_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","volume":"64","author":"CA Whitehouse","year":"2004","unstructured":"Whitehouse CA (2004) Crimean-Congo hemorrhagic fever. Antivir Res 64:145\u2013160. \n                        https:\/\/doi.org\/10.1016\/j.antiviral.2004.08.001","journal-title":"Antivir Res"},{"key":"3653_CR4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3201\/eid1008.030928","volume":"10","author":"SS Karti","year":"2004","unstructured":"Karti SS, Odabasi Z, Korten V et al (2004) Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 10:1379\u20131384","journal-title":"Emerg Infect Dis"},{"key":"3653_CR5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","volume":"6","author":"\u00d6 Erg\u00f6n\u00fcl","year":"2006","unstructured":"Erg\u00f6n\u00fcl \u00d6 (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6:203\u2013214","journal-title":"Lancet Infect Dis"},{"key":"3653_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.07.006","author":"DA Bente","year":"2013","unstructured":"Bente DA, Forester NL, Watts DM et al (2013) Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antivir Res. \n                        https:\/\/doi.org\/10.1016\/j.antiviral.2013.07.006","journal-title":"Antivir Res"},{"key":"3653_CR7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0955-0674(92)90102-I","volume":"4","author":"TN Wight","year":"1992","unstructured":"Wight TN, Kinsella MG, Qwarnstr\u00f6m EE (1992) The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 4:793\u2013801","journal-title":"Curr Opin Cell Biol"},{"key":"3653_CR8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.CCM.0000199054.13823.A7","volume":"34","author":"JG Filep","year":"2006","unstructured":"Filep JG (2006) Endocan or endothelial cell-specific molecule-1: a novel prognostic marker of sepsis? Crit Care Med 34:574\u2013575","journal-title":"Crit Care Med"},{"key":"3653_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrc842","volume":"2","author":"R Sasisekharan","year":"2002","unstructured":"Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2:1\u20138. \n                        https:\/\/doi.org\/10.1038\/nrc842","journal-title":"Nat Rev Cancer"},{"key":"3653_CR10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.CCM.0000198525.82124.74","volume":"34","author":"A Scherpereel","year":"2006","unstructured":"Scherpereel A, Depontieu F, Grigoriu B et al (2006) Endocan, a new endothelial marker in human sepsis. Crit Care Med 34:532\u2013537","journal-title":"Crit Care Med"},{"issue":"8","key":"3653_CR11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0300-9084(01)01290-1","volume":"83","author":"D Spillmann","year":"2001","unstructured":"Spillmann D (2001) Heparan sulfate: anchor for viral intruders? Biochimie 83(8):811\u2013817","journal-title":"Biochimie"},{"key":"3653_CR12","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1158\/1078-0432.CCR-06-0185","volume":"12","author":"BD Grigoriu","year":"2006","unstructured":"Grigoriu BD, Depontieu F, Scherpereel A et al (2006) Endocan expression and relationship with survival in human non small cell lung cancer. Clin Cancer Res 12:4575\u20134583. \n                        https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0185","journal-title":"Clin Cancer Res"},{"key":"3653_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbcan.2005.08.004","volume":"1765","author":"S Sarrazin","year":"2006","unstructured":"Sarrazin S, Adam E, Lyon M et al (2006) Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 1765:25\u201337. \n                        https:\/\/doi.org\/10.1016\/j.bbcan.2005.08.004","journal-title":"Biochim Biophys Acta"},{"key":"3653_CR14","doi-asserted-by":"publisher","first-page":"20458","DOI":"10.1074\/jbc.271.34.20458","volume":"271","author":"P Lassalle","year":"1996","unstructured":"Lassalle P, Molet S, Janin A et al (1996) ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 271:20458\u201320464. \n                        https:\/\/doi.org\/10.1074\/jbc.271.34.20458","journal-title":"J Biol Chem"},{"issue":"4","key":"3653_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/0003319715590558","volume":"67","author":"N Altintas","year":"2016","unstructured":"Altintas N, Mutlu LC, Akkoyun DC et al (2016) Effect of CPAP on new endothelial dysfunction marker, endocan. People with obstructive sleep apnea. Angiology 67(4):364\u2013374. \n                        https:\/\/doi.org\/10.1177\/0003319715590558","journal-title":"Angiology"},{"key":"3653_CR16","doi-asserted-by":"publisher","first-page":"48341","DOI":"10.1074\/jbc.M108395200","volume":"276","author":"D Bechard","year":"2001","unstructured":"Bechard D, Gentina T, Delehedde M, Scherpereel A et al (2001) Endocan is a novel chondroitin sulfate\/dermatan sulfate proteoglycan that promotes hepatocyte growth factor\/scatter factor mitogenic activity. J Biol Chem 276:48341\u201348349. \n                        https:\/\/doi.org\/10.1074\/jbc.M108395200","journal-title":"J Biol Chem"},{"key":"3653_CR17","first-page":"384","volume":"32","author":"PM Ridker","year":"2005","unstructured":"Ridker PM (2005) C-reactive protein, inflammation, and cardiovascular disease: clinical update. Curr Issues Cardiol 32:384\u2013386","journal-title":"Curr Issues Cardiol"},{"key":"3653_CR18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3949\/ccjm.56.2.126","volume":"56","author":"S Deodhar","year":"1989","unstructured":"Deodhar S (1989) C-Reactive protein: the best laboratory indicator available for monitoring disease activity. Cleve Clin J Med 56:126\u2013130","journal-title":"Cleve Clin J Med"},{"key":"3653_CR19","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1161\/01.ATV.19.4.972","volume":"19","author":"JS Yudkin","year":"1999","unstructured":"Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW (1999) C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972\u2013978. \n                        https:\/\/doi.org\/10.1161\/01.ATV.19.4.972","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3653_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s001250051162","volume":"42","author":"CG Schalkwijk","year":"1999","unstructured":"Schalkwijk CG, Poland DCW, Van Dijk W et al (1999) Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42:351\u2013357. \n                        https:\/\/doi.org\/10.1007\/s001250051162","journal-title":"Diabetologia"},{"key":"3653_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","volume":"107","author":"S Devaraj","year":"2003","unstructured":"Devaraj S, Xu D, Jialal I (2003) C-Reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107:398\u2013404. \n                        https:\/\/doi.org\/10.1161\/01.CIR.0000052617.91920.FD","journal-title":"Circulation"},{"key":"3653_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/ATVBAHA.107.160903","volume":"28","author":"J Wu","year":"2008","unstructured":"Wu J, Stevenson MJ, Brown JM et al (2008) C-Reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arterioscler Thromb Vasc Biol 28:698\u2013704. \n                        https:\/\/doi.org\/10.1161\/ATVBAHA.107.160903","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3653_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cardiores.2005.05.010","volume":"68","author":"P Cirillo","year":"2005","unstructured":"Cirillo P, Golino P, Calabr\u00f2 P et al (2005) C-Reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 68:47\u201355. \n                        https:\/\/doi.org\/10.1016\/j.cardiores.2005.05.010","journal-title":"Cardiovasc Res"},{"key":"3653_CR24","unstructured":"Cermak J, Key NS, Bach RR et al (1993) C-Reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82:513\u2013520. papers3:\/\/publication\/uuid\/1B1B9252-69D3-4DCE-BC48-75A6483C38A6"},{"key":"3653_CR25","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/j.1538-7836.2011.04270.x","volume":"9","author":"J-C Gris","year":"2011","unstructured":"Gris J-C, Faillie J-L, Cochery-Nouvellon \u00c9 et al (2011) ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs d-dimer assay. J Thromb Haemost 9:1252\u20131255. \n                        https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04270.x","journal-title":"J Thromb Haemost"},{"key":"3653_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/0253-7184.192127","volume":"37","author":"A Vishwanath","year":"2016","unstructured":"Vishwanath A, Quaiser S, Khan R (2016) Role of high-sensitivity C-reactive protein measurements in HIV patients. Indian J Sex Transm Dis AIDS 37:123. \n                        https:\/\/doi.org\/10.4103\/0253-7184.192127","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"3653_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10096-014-2238-0","volume":"34","author":"M Bak\u0131r","year":"2014","unstructured":"Bak\u0131r M, G\u00f6zel MG, K\u00f6ksal I et al (2014) Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF). Eur J Clin Microbiol Infect Dis 34:325\u2013330. \n                        https:\/\/doi.org\/10.1007\/s10096-014-2238-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3653_CR28","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/cid\/cit527","volume":"57","author":"B Dokuzoguz","year":"2013","unstructured":"Dokuzoguz B, Celikbas AK, G\u00f6k \u015eE et al (2013) Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis 57:1270\u20131274. \n                        https:\/\/doi.org\/10.1093\/cid\/cit527","journal-title":"Clin Infect Dis"},{"key":"3653_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/or.2012.2012","volume":"28","author":"JH Kim","year":"2012","unstructured":"Kim JH, Park MY, Kim CN et al (2012) Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1\u03b1 in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features. Oncol Rep 28:1701\u20131708. \n                        https:\/\/doi.org\/10.3892\/or.2012.2012","journal-title":"Oncol Rep"},{"key":"3653_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/NEN.0b013e3181a52a7f","volume":"68","author":"C-A Maurage","year":"2009","unstructured":"Maurage C-A, Adam E, Min\u00e9o J-F et al (2009) Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol 68:633\u2013641. \n                        https:\/\/doi.org\/10.1097\/NEN.0b013e3181a52a7f","journal-title":"J Neuropathol Exp Neurol"},{"key":"3653_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4081\/ejh.2011.e13","volume":"55","author":"LM Carrillo","year":"2011","unstructured":"Carrillo LM, Arciniegas E, Rojas HR, Ramirez RE (2011) Immunolocalization of endocan during the endothelial\u2013mesenchymal transition process. Eur J Histochem 55:73\u201377. \n                        https:\/\/doi.org\/10.4081\/ejh.2011.e13","journal-title":"Eur J Histochem"},{"key":"3653_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/705027","author":"M Delehedde","year":"2013","unstructured":"Delehedde M, Devenyns L, Maurage CAVR (2013) Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. \n                        https:\/\/doi.org\/10.1155\/2013\/705027","journal-title":"Int J Cell Biol"},{"key":"3653_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jmv.24647","volume":"89","author":"G Yilmaz","year":"2017","unstructured":"Yilmaz G, Yilmaz H, Arslan M et al (2017) The prognostic significance of serum TGF-\u03b21 levels in patients with Crimean-Congo hemorrhagic fever. J Med Virol 89:413\u2013416. \n                        https:\/\/doi.org\/10.1002\/jmv.24647","journal-title":"J Med Virol"},{"key":"3653_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24881","author":"M Arslan","year":"2017","unstructured":"Arslan M, Yilmaz G, Mentese A et al (2017) Importance of endothelial dysfunction biomarkers in patients with Crimean-Congo hemorrhagic fever. J Med Virol. \n                        https:\/\/doi.org\/10.1002\/jmv.24881","journal-title":"J Med Virol"},{"key":"3653_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jcv.2010.01.010","volume":"47","author":"G Yilmaz","year":"2010","unstructured":"Yilmaz G, Koksal I, Topbas M et al (2010) The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: Severity prediction criteria. J Clin Virol 47:361\u2013365. \n                        https:\/\/doi.org\/10.1016\/j.jcv.2010.01.010","journal-title":"J Clin Virol"},{"key":"3653_CR36","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/jmv.24446","volume":"88","author":"M Bakir","year":"2016","unstructured":"Bakir M, Engin A, Kuskucu MA et al (2016) Relationship of plasma cell-free DNA level with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J Med Virol 88:1152\u20131158. \n                        https:\/\/doi.org\/10.1002\/jmv.24446","journal-title":"J Med Virol"},{"key":"3653_CR37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-12-1855","volume":"73","author":"F Roudnicky","year":"2013","unstructured":"Roudnicky F, Poyet C, Wild P et al (2013) Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res 73:1097\u20131106. \n                        https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1855","journal-title":"Cancer Res"},{"key":"3653_CR38","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.yexcr.2007.01.021","volume":"313","author":"E Rennel","year":"2007","unstructured":"Rennel E, Mellberg S, Dimberg A et al (2007) Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp Cell Res 313:1285\u20131294. \n                        https:\/\/doi.org\/10.1016\/j.yexcr.2007.01.021","journal-title":"Exp Cell Res"},{"key":"3653_CR39","doi-asserted-by":"publisher","first-page":"e704","DOI":"10.1016\/j.ijid.2010.02.2240","volume":"14","author":"H Bodur","year":"2010","unstructured":"Bodur H, Ak\u0131nc\u0131 E, \u00d6ng\u00fcr\u00fc P et al (2010) Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis 14:e704\u2013e707. \n                        https:\/\/doi.org\/10.1016\/j.ijid.2010.02.2240","journal-title":"Int J Infect Dis"},{"key":"3653_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/936062","volume":"2015","author":"C-C Chen","year":"2015","unstructured":"Chen C-C, Lee I-K, Liu J-W et al (2015) Utility of C-reactive protein levels for early prediction of dengue severity in adults. Biomed Res Int 2015:1\u20136. \n                        https:\/\/doi.org\/10.1155\/2015\/936062","journal-title":"Biomed Res Int"},{"key":"3653_CR41","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/infdis\/jiu088","volume":"210","author":"AK McElroy","year":"2014","unstructured":"McElroy AK, Erickson BR, Flietstra TD et al (2014) Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 210:558\u2013566. \n                        https:\/\/doi.org\/10.1093\/infdis\/jiu088","journal-title":"J Infect Dis"},{"key":"3653_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.17305\/bjbms.2013.2408","volume":"13","author":"I Sari","year":"2013","unstructured":"Sari I, Bakir S, Engin A et al (2013) Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever. Bosn J Basic Med Sci 13:21\u201326","journal-title":"Bosn J Basic Med Sci"},{"key":"3653_CR43","doi-asserted-by":"publisher","first-page":"e0123358","DOI":"10.1371\/journal.pone.0123358","volume":"10","author":"K Seo","year":"2015","unstructured":"Seo K, Kitazawa T, Yoshino Y et al (2015) Characteristics of serum endocan levels in infection. PLoS One 10:e0123358. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0123358","journal-title":"PLoS One"},{"key":"3653_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131:417\u2013430. \n                        https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05753.x","journal-title":"Br J Haematol"},{"key":"3653_CR45","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/jmv.23922","volume":"86","author":"E Mostafavi","year":"2014","unstructured":"Mostafavi E, Pourhossein B, Chinikar S (2014) Clinical symptoms and laboratory findings supporting early diagnosis of Crimean-Congo hemorrhagic fever in Iran. J Med Virol 86:1188\u20131192. \n                        https:\/\/doi.org\/10.1002\/jmv.23922","journal-title":"J Med Virol"},{"key":"3653_CR46","first-page":"18302","volume":"8","author":"E Parlak","year":"2015","unstructured":"Parlak E, Ert\u00fcrk A, \u00c7a\u011f Y et al (2015) The effect of inflammatory cytokines and the level of vitamin D on prognosis in Crimean-Congo hemorrhagic fever. Int J Clin Exp Med 8:18302\u201318310","journal-title":"Int J Clin Exp Med"},{"key":"3653_CR47","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7883\/yoken.JJID.2015.392","volume":"69","author":"\u00d6 Demirpen\u00e7e","year":"2016","unstructured":"Demirpen\u00e7e \u00d6, Do\u011fan HO, Er\u015fan S et al (2016) Presepsin levels of patients with Crimean-Congo hemorrhagic fever. Jpn J Infect Dis 69:505\u2013509. \n                        https:\/\/doi.org\/10.7883\/yoken.JJID.2015.392","journal-title":"Jpn J Infect Dis"},{"key":"3653_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jcla.20383","volume":"24","author":"P Onguru","year":"2010","unstructured":"Onguru P, Dagdas S, Bodur H et al (2010) Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Clin Lab Anal 24:163\u2013166. \n                        https:\/\/doi.org\/10.1002\/jcla.20383","journal-title":"J Clin Lab Anal"},{"key":"3653_CR49","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1365-2141.2007.06968.x","volume":"140","author":"YL Chee","year":"2008","unstructured":"Chee YL, Crawford JC, Watson HG, Greaves M (2008) Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. Br J Haematol 140:496\u2013504. \n                        https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06968.x","journal-title":"Br J Haematol"},{"key":"3653_CR50","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1161\/01.ATV.0000183718.62409.ea","volume":"25","author":"U Singh","year":"2005","unstructured":"Singh U (2005) C-Reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 25:2216\u20132221. \n                        https:\/\/doi.org\/10.1161\/01.ATV.0000183718.62409.ea","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-017-3653-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T07:09:35Z","timestamp":1518678575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-017-3653-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3653"],"URL":"https:\/\/doi.org\/10.1007\/s00705-017-3653-1","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}